Bajaj Finance accelerated provisioning for Covid19- Bullish
Bajaj Finance informed on Monday it may consider additional accelerated provisioning for Covid-19 in the first quarter of fiscal year 2021 to further strengthen its balance sheet.
BajFin were moving between 200EMA (Resistance) and 100EMA (Support) and also following the levels on Fib ret.
Today stock made High above 200EMA but closed below.Today volume was 11.438M < 12.929M (20MA Volume).
Stock is outperforming Benchmark and Sectrol both index in 1 month and 3 month time period.
Showing BULLISH in all indicator:
CCI above +100
RSI near to overbought
Stoch in overbought
ROC is Trending UP
DI+ crossed 33 from below
Stock outperforming from Benchmark and Sectoral Index
Increase in Relative Strength - Benchmark/Sectrol Index
Aggressive New Long
White Marubozu
----------------------------------------------------------
Support : 3010
Breakdown : 3097
CMP : 3108
Breakout : 3128
Short Target : 3150 and 3200
----------------------------------------------------------
(Disclaimer: This is only for educational purpose.)
BajFin were moving between 200EMA (Resistance) and 100EMA (Support) and also following the levels on Fib ret.
Today stock made High above 200EMA but closed below.Today volume was 11.438M < 12.929M (20MA Volume).
Stock is outperforming Benchmark and Sectrol both index in 1 month and 3 month time period.
Showing BULLISH in all indicator:
CCI above +100
RSI near to overbought
Stoch in overbought
ROC is Trending UP
DI+ crossed 33 from below
Stock outperforming from Benchmark and Sectoral Index
Increase in Relative Strength - Benchmark/Sectrol Index
Aggressive New Long
White Marubozu
----------------------------------------------------------
Support : 3010
Breakdown : 3097
CMP : 3108
Breakout : 3128
Short Target : 3150 and 3200
----------------------------------------------------------
(Disclaimer: This is only for educational purpose.)
Trade closed: target reached
Both Upper Target Hit..........
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.